May 29, 2025 (Pfizer Inc. (via LinkedIn)) –
Pfizer Inc. posted 56 LinkedIn updates from May 22 to May 29, 2025. The company's posts covered a wide range of topics, including research and development, sustainability initiatives, corporate social responsibility, and global health efforts. Let's delve into the key areas of focus for Pfizer during this period.
Research and Innovation
Pfizer continues to demonstrate its commitment to scientific advancement and innovation across various therapeutic areas. The company highlighted significant progress in oncology research, sharing new 5-year overall survival data in metastatic hormone-sensitive prostate cancer. This update marks another step forward in Pfizer's decade-long collaboration with Astellas Pharma to improve care for people with advanced prostate cancer.
In the field of hematology, Pfizer is making strides in developing new treatments for multiple myeloma. The company is exploring innovative approaches such as bispecific antibodies, CAR-T cell therapies, and antibody-drug conjugates (ADCs) to improve life expectancy and quality of life for patients with this form of blood cancer.
Pfizer also highlighted its ongoing efforts in vaccine development and research. The company emphasized the importance of vaccination in preventing life-threatening infections and addressed common misconceptions about vaccine safety. Pfizer continues to invest in vaccine research and development to protect public health and prevent the spread of infectious diseases.
New survival data in prostate cancer
Innovative approaches in multiple myeloma
Addressing vaccine misconceptions and safety
Global Health Initiatives
Pfizer's commitment to global health equity was evident in several posts. The company highlighted its Accord for a Healthier World initiative, which aims to provide access to Pfizer's portfolio of medicines and vaccines on a not-for-profit basis to eligible lower-income countries. As part of this program, Pfizer is collaborating with global health leaders to address systemic barriers to access, including through medical education and training.
The company shared a success story from Rwanda, where Dr. Janvier Murayire, a Rheumatologist and Internal Medicine Physician, has trained over 10 physician specialists who have helped provide care to more than 2,500 patients in the country, supported by resources provided through the Accord.
Pfizer also addressed healthcare disparities in Europe, particularly focusing on the "Underserved Within" phenomenon. This refers to people from mixed economic backgrounds within the same communities who face complex barriers to accessing healthcare, including vaccination. The company partnered with the Association Excellence in Pediatrics Institute to release a report on this often-overlooked issue in public health.
Accord for a Healthier World initiative
Addressing vaccination disparities in Europe
Corporate Social Responsibility and Diversity
Pfizer demonstrated its commitment to corporate social responsibility and diversity through various initiatives. The company celebrated the German Diversity Day, emphasizing the importance of diversity and equal opportunities in the workplace. Pfizer has been a signatory to the Diversity Charter since 2008 and continues to promote inclusivity and equality among its approximately 3,000 employees in Germany.
In Canada, Pfizer supported the Push for Your Tush event, a 5km walk/run dedicated to raising awareness and encouraging screening for colon cancer. The company used this opportunity to highlight the importance of early detection and prioritizing the health of Canadians.
Pfizer also announced its recognition as a Great Place to Work® 2025 in Portugal, validating the company's ongoing commitment to creating an inclusive, flexible, and employee-focused work environment.
Celebrating German Diversity Day
Supporting colon cancer awareness in Canada
Great Place to Work certification in Portugal
Education and Patient Support
Pfizer continues to prioritize patient education and support through various initiatives. The company launched "Pfizer Conmigo," a platform providing reliable content and secure medical information to help individuals manage their health. This initiative demonstrates Pfizer's commitment to empowering patients with knowledge and resources.
In Spain, Pfizer announced its participation in the Madrid Book Fair, where it will showcase a collection of children's books aimed at promoting reading and introducing science to young readers. This initiative reflects Pfizer's efforts to engage with the community and foster scientific interest from an early age.
The company also organized educational events for healthcare professionals, including a masterclass series for GPs and practice teams on invasive pneumococcal disease, which is currently at its highest rate in two decades.
Launch of Pfizer Conmigo platform
Participation in Madrid Book Fair
Masterclass on invasive pneumococcal disease
Other Notable Updates
Pfizer shared updates on various other initiatives, including its efforts to promote women's health, raise awareness about bladder cancer, and support smoking cessation programs. The company also highlighted its recognition as a top employer in the pharmaceutical sector in Mexico, emphasizing its commitment to attracting and retaining talent.
In conclusion, Pfizer's LinkedIn activity during this period showcases a company deeply committed to scientific innovation, global health equity, and corporate social responsibility. From groundbreaking research in oncology and hematology to initiatives addressing healthcare disparities and promoting patient education, Pfizer continues to position itself as a leader in the pharmaceutical industry, driving positive change on a global scale.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.